Celltrion News on
HackerNoon and Around the Web

Celltrion, Inc. researches, develops, manufactures, and distributes therapeutics based on recombinant DNA and molecular biology in Korea and internationally. It operates through ...

Celltrion expects Covid variants to fuel global treatments growthPublished at Jul 04, 2021 by The Financial Times

EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategyPublished at Jun 30, 2021 by PMLiVE

COVID-19 Test Kit Makers Prepare for Post-Coronavirus EraPublished at Jun 30, 2021 by The Korea Bizwire

Tag: South KoreaPublished at Jun 29, 2021 by GeneOnline News

Biogeneric Drugs Market Size Volume, Share, Demand growth, Business Opportunity by 2028Published at Jun 28, 2021 by MarketWatch

EY World Entrepreneur Of The Year™ 2021Published at Jun 25, 2021 by CNBC

Short-Sellers Set Their Sights on Surging Asia Biotech StocksPublished at Jun 25, 2021 by bnnbloomberg

New targets and DNA modifying payload addition set to enhance ADC work at IksudaPublished at Jun 24, 2021 by biopharma-reporter

Jury awards former AstraZeneca sales manager $2.4M in whistleblower retaliation casePublished at Jun 23, 2021 by FiercePharma

Metastatic Colorectal Cancer Pipeline Market 2016 Global Outlook Analysis ResearchPublished at Jun 23, 2021 by News Maker